Observational × Ovarian Neoplasms × Gastrointestinal × Clear all National Cancer Institute "Cancer Moonshot Biobank"
Active not recruiting
1,600 enrolled
TraveraRTGx
Completed
72 enrolled
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Recruiting
1,000 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
DP-04
Recruiting
100 enrolled
ASAP
Recruiting
25,000 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
PRO-ACTIVE
Recruiting
850 enrolled
BASECAMP-1
Recruiting
200 enrolled
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
Completed
64 enrolled
iCaRe2
Recruiting
999,999 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Active not recruiting
992 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
Completed
22 enrolled
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Recruiting
250 enrolled
LIBERATE
Recruiting
2,500 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
Active not recruiting
1,047 enrolled
COSMOS
Not yet recruiting
248 enrolled
OLAP
Completed
661 enrolled
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Terminated
19 enrolled
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Completed
7 enrolled
DESCENT-1
Enrolling by invitation
400 enrolled
PRIORITY
Completed
346 enrolled 9 charts
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
Recruiting
1,200 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
LONGEVITI
Recruiting
75 enrolled
PREFER
Completed
1,429 enrolled
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
Recruiting
100 enrolled
INSPIRE
Recruiting
5,350 enrolled
MOHCCN-O
Recruiting
500 enrolled
REFLECT
Recruiting
120 enrolled
ROOT
Completed
167 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Recruiting
400 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
AURA
Completed
13 enrolled
Registry for Women Who Are At Risk Or May Have Lynch Syndrome
Completed
323 enrolled
RADIANT
Completed
16 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
CER
Recruiting
15,000 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Unknown
2,700 enrolled
A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
Completed
120 enrolled
A Follow-up Study of Women Evaluated and Treated for Infertility
Completed
12,193 enrolled
CUSIOS
Completed
400 enrolled
POPCORN
Recruiting
782 enrolled
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Completed
16,506 enrolled